US-approved vaccines effective against B1617 variant of Covid-19: US health official

WHO classified the B1617 SARS-CoV-2 variant, and confirmed that the variant was first detected in India

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

Should there be a lesson on Jinnah?: Karnataka K.S. Eshwarappa asks

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation